Erratum corrects funding information without altering scientific conclusions of colorectal cancer study.
In the article “Single-cell mapping of tumor-driven macrophage reprogramming via ETV4-MC1R underlies immunotherapy resistance in colorectal cancer”[1], the grant number for the Yunnan Fundamental Research Projects was incorrect. The correct funding statement is below:This study was supported by the National Natural Science Foundation of China (No.82560608 to TW), Yunnan Fundamental Research Projects (No.202501AT070039 to TW), Science and Technology Planning Project of Yunnan (202401AY070001-269 to TW), and Scientific Research Fund of the Yunnan Provincial Education Department (2024J0299 to LX). All other content of the article remains unchanged. This correction does not affect the scientific conclusions of the paper.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: